Coaptite lnjectable lmplant
FDA premarket approval P040047/S055 · decided 2019-11-06
Approval details
- PMA number
- P040047
- Supplement
- S055
- Supplement type
- 135 Review Track For 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Coaptite lnjectable lmplant
- Generic name
- AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
- Applicant
- Merz North America, Inc.
- Date received
- 2019-05-16
- Decision date
- 2019-11-06
- Days to decision
- 174 days
- Decision code
- APPR
- Product code
- LNM
- Advisory committee
- Gastroenterology, Urology
- Expedited review
- No
- Location
- Franksville, WI
- Statement
- Approval for modifications to the manufacturing equipment for Coaptite Injectable Implant, Radiesse Injectable Implant, and Radiesse (+) Lidocaine Dermal Filler.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| DESCRIBE PFD Patch (K172689) | Merz North America, Inc. | 2017-11-29 |